Medical Net, Inc.
3645.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | -5.89 | -0.43 | 0.06 |
| FCF Yield | -7.51% | 2.61% | 11.60% | 8.35% |
| EV / EBITDA | 23.16 | 13.27 | 8.85 | 6.51 |
| Quality | ||||
| ROIC | -4.59% | 1.71% | 6.02% | 13.15% |
| Gross Margin | 32.28% | 35.05% | 39.57% | 38.98% |
| Cash Conversion Ratio | 1.19 | 20.07 | 3.70 | 0.89 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.49% | 11.93% | 15.72% | 8.68% |
| Free Cash Flow Growth | -344.73% | -78.75% | 20.01% | -10.15% |
| Safety | ||||
| Net Debt / EBITDA | -1.80 | -2.34 | -2.30 | -0.63 |
| Interest Coverage | 8.16 | 46.45 | 125.46 | 225.49 |
| Efficiency | ||||
| Inventory Turnover | 12.91 | 16.53 | 21.94 | 17.67 |
| Cash Conversion Cycle | 45.08 | 33.35 | 28.00 | 43.93 |